MIRM vs. TGTX
Compare and contrast key facts about Mirum Pharmaceuticals, Inc. (MIRM) and TG Therapeutics, Inc. (TGTX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MIRM or TGTX.
Correlation
The correlation between MIRM and TGTX is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MIRM vs. TGTX - Performance Comparison
Loading data...
Key characteristics
MIRM:
112.49%
TGTX:
53.63%
MIRM:
-7.13%
TGTX:
-10.72%
MIRM:
-2.14%
TGTX:
-10.72%
Fundamentals
MIRM:
$2.19B
TGTX:
$5.34B
MIRM:
-$1.61
TGTX:
$0.25
MIRM:
5.77
TGTX:
13.82
MIRM:
9.39
TGTX:
22.51
MIRM:
$379.25M
TGTX:
$265.53M
MIRM:
$292.42M
TGTX:
$232.41M
MIRM:
-$33.56M
TGTX:
$57.77M
Returns By Period
MIRM
N/A
N/A
N/A
N/A
N/A
N/A
TGTX
N/A
N/A
N/A
N/A
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MIRM vs. TGTX — Risk-Adjusted Performance Rank
MIRM
TGTX
MIRM vs. TGTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Mirum Pharmaceuticals, Inc. (MIRM) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
MIRM vs. TGTX - Dividend Comparison
Neither MIRM nor TGTX has paid dividends to shareholders.
Drawdowns
MIRM vs. TGTX - Drawdown Comparison
The maximum MIRM drawdown since its inception was -7.13%, smaller than the maximum TGTX drawdown of -10.72%. Use the drawdown chart below to compare losses from any high point for MIRM and TGTX. For additional features, visit the drawdowns tool.
Loading data...
Volatility
MIRM vs. TGTX - Volatility Comparison
Loading data...
Financials
MIRM vs. TGTX - Financials Comparison
This section allows you to compare key financial metrics between Mirum Pharmaceuticals, Inc. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MIRM vs. TGTX - Profitability Comparison
MIRM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Mirum Pharmaceuticals, Inc. reported a gross profit of 88.57M and revenue of 111.59M. Therefore, the gross margin over that period was 79.4%.
TGTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, TG Therapeutics, Inc. reported a gross profit of 92.79M and revenue of 108.19M. Therefore, the gross margin over that period was 85.8%.
MIRM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Mirum Pharmaceuticals, Inc. reported an operating income of -15.18M and revenue of 111.59M, resulting in an operating margin of -13.6%.
TGTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, TG Therapeutics, Inc. reported an operating income of 29.95M and revenue of 108.19M, resulting in an operating margin of 27.7%.
MIRM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Mirum Pharmaceuticals, Inc. reported a net income of -14.68M and revenue of 111.59M, resulting in a net margin of -13.2%.
TGTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, TG Therapeutics, Inc. reported a net income of 23.33M and revenue of 108.19M, resulting in a net margin of 21.6%.